RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

Purpose: To evaluate the effects of total body irradiation (TBI), as a conditioning regimen prior to allogeneic stem cell transplantation (allo-SCT), in pediatric acute leukemia patients. Materials and Methods: From January 2001 to December 2011, 28 patients, aged less than 18 years, were treated with TBI-based conditioning for allo-SCT in our institution. Of the 28 patients, 21 patients were diagnosed with acute lymphoblastic leukemia (ALL, 75%) and 7 were diagnosed with acute myeloid leukemia (AML, 25%). TBI was completed 4 days or 1 day before stem cell infusion. Patients underwent radiation therapy with bilateral parallel opposing fields and 6-MV X-rays. The Kaplan-Meier method was used to calculate survival outcomes. Results: The 2-year event-free survival and overall survival rates were 66% and 56%, respectively (71.4% and 60.0% in AML patients vs. 64.3% and 52.4% in ALL patients, respectively). Treatment related mortality rate were 25%. Acute and chronic graft-versus-host disease was a major complication; other complications included endocrine dysfunction and pulmonary complications. Common complications from TBI were nausea (89%) and cataracts (7.1%). Conclusion: The efficacy and toxicity data in this study of TBI-based conditioning to pediatric acute leukemia patients were comparable with previous studies. However, clinicians need to focus on the acute and chronic complications related to allo-SCT.

목차 (Table of Contents)

1. Introduction
2. Materials and Methods
3. Results
4. Discussion and Conclusion
5. Conflict of Interest

1. Introduction
2. Materials and Methods
3. Results
4. Discussion and Conclusion
5. Conflict of Interest
6. References

참고문헌 (Reference)

1 Sierra J, "Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience" 26 : 397-404, 2000

2 Pulte D, "Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004" 100 : 1301-1309, 2008

3 Creutzig U, "Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials" 19 : 2030-2042, 2005

4 Mateos MK, "Transplant-related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia:25-year retrospective review" 60 : 1520-1527, 2013

5 Chou RH, "Toxicities of total-body irradiation for pediatric bone marrow transplantation" 34 : 843-851, 1996

6 Shi-Xia X, "Total body irradiation plus cyclophosphamide versus busulphan with cyclophosphamide as conditioning regimen for patients with leukemia undergoing allogeneic stem cell transplantation: a meta-analysis" 51 : 50-60, 2010

7 Rovelli A, "The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children" 21 : 577-581, 1998

8 Hartman AR, "Survival, diseasefree survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan/cyclophosphamide vs total body irradiation: a meta-analysis" 22 : 439-443, 1998

9 Hows J, "Prospective evaluation of unrelated donor bone marrow transplantation. The International Marrow Unrelated Search and Transplant (IMUST) Study" 12 : 371-380, 1993

10 Lange BJ, "Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group" 111 : 1044-1053, 2008